Open-Label, Long-Term (1 Year) Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
Open-Label, Long-Term (1 Year) Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
This study is a long-term follow-up protocol for patients who participated in study NK-104-3.01EU or study NK-104-3.02EU.
Patients from the NK-104-3.01EU and NK-104-3.02EU studies will continue to receive either pitavastatin or the comparator statin for 1 year.
Inclusion Criteria:
Exclusion Criteria:
Copenhagen Nv, Denmark
Bad Soden/Taunus, Germany
Berlin-Spandau, Germany
Melcherstaette, Germany
Offenbach/M, Germany
Andhra Pradesh, 500034, India
Andhra Pradesh, 500082, India
Gujarat, 380054, India
Karnataka, 560034, India
Maharashtra, 400007, India
Maharashtra, 400022, India
Maharashtra, 400027, India
Maharashtra, 411001, India
Maharashtra, 411001, India
Maharashtra, 411033, India
Tamil Nadu, 600006, India
Tamil Nadu, 641004, India
Beersheva, Israel
Jerusalem Ein Kerem, Israel
Mount Scopus Jerusalem, Israel
Wp Tiel, Netherlands
Gruziadz, Poland
Moscow, Russia
Moscow, Russia
Moscow, Russia
Moscow, Russia
Moscow, Russia
Moscow, Russia
Moscow, Russia
Moscow, Russia
Moscow, Russia
Saint Petersburg, Russia
Saint Petersburg, Russia
Saint Petersburg, Russia
Villaroel, Barcelona, Spain
Angelhom, Sweden
Karineholm, Sweden
Cornwall, United Kingdom
Surrey, United Kingdom
Wiltshire, United Kingdom
Wiltshire, United Kingdom
Wiltshire, United Kingdom
Wiltshire, United Kingdom
Wiltshire, United Kingdom
Wiltshire, United Kingdom
Wiltshire, United Kingdom
Wiltshire, United Kingdom
Yorkshire, United Kingdom